H-CSPGAKVRC-OH

Ref. 3D-PP49414

Produktinformation

• Name: H-CSPGAKVRC-OH

Beschreibung

Peptide H-CSPGAKVRC-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-CSPGAKVRC-OH include the following: Melanoma immunotherapy enabled by M2 macrophage targeted immunomodulatory cowpea mosaic virus Z Zhao , YH Chung , NF Steinmetz - Materials Advances, 2024 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2024/ma/d3ma00820g Targeting macrophages for tumor therapy Y Wang, A Barrett, Q Hu - The AAPS Journal, 2023 - Springerhttps://link.springer.com/article/10.1208/s12248-023-00845-y Tumor Associated Macrophages and TAMs-Based Anti-Tumor Nanomedicines Y Cheng , S Song, P Wu, B Lyu, M Qin - Advanced , 2021 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/adhm.202100590 Recent progress in functional peptides designed for tumor-targeted imaging and therapy XY Wang , YH Wang, Z Song, XY Hu, JP Wei - Journal of Materials , 2021 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2021/tc/d0tc05405d In vitro characterization and cellular uptake profiles of TAMs-targeted lipid calcium carbonate nanoparticles for cancer immunotherapy X Xu, R Li, R Dong, Y Yang, H Wang - Acta Materia , 2022 - ucl.scienceopen.comhttps://ucl.scienceopen.com/hosted-document?doi=10.15212/AMM-2022-0030 Phage display to augment biomaterial function TA Davidson, SJ McGoldrick, DH Kohn - International Journal of , 2020 - mdpi.comhttps://www.mdpi.com/1422-0067/21/17/5994 Interface Engineering through Adhesion and Remineralization for Dental Composites using Mineral Binding Peptides T Davidson - 2022 - deepblue.lib.umich.eduhttps://deepblue.lib.umich.edu/handle/2027.42/172619 Precision targeting of tumor macrophages with a CD206 binding peptide P Scodeller , L Simon-Gracia , S Kopanchuk, A Tobi - Scientific reports, 2017 - nature.comhttps://www.nature.com/articles/s41598-017-14709-x/briefing/signup Targeting tumors using peptides P Scodeller , EK Asciutto - Molecules, 2020 - mdpi.comhttps://www.mdpi.com/1420-3049/25/4/808 Generation of novel diagnostic and therapeutic exosomes to detect and deplete protumorigenic M2 macrophages MH Rashid , TF Borin , R Ara, A Alptekin - Advanced , 2020 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/adtp.201900209 Current therapeutic approaches and promising perspectives of using bioengineered peptides in fighting chemoresistance in triple-negative breast cancer M Azari, F Bahreini , VN Uversky , N Rezaei - Biochemical Pharmacology, 2023 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006295223000503 Peritoneal carcinomatosis targeting with tumor homing peptides L Simon-Gracia , H Hunt, T Teesalu - Molecules, 2018 - mdpi.comhttps://www.mdpi.com/1420-3049/23/5/1190 Fluorescent, phosphorescent, magnetic resonance contrast and radioactive tracer labelling of extracellular vesicles K Wardhani, A Levina , GER Grau , PA Lay - Chemical Society Reviews, 2024 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2024/cs/d2cs00238h Glycan-Mediated Targeting Methods K Vong , K Tanaka, K Fukase - of In Vivo Chemistry in Mice , 2020 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/9783527344406.ch17 Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses JM Jaynes, R Sable, M Ronzetti , W Bautista - Science translational , 2020 - science.orghttps://www.science.org/doi/abs/10.1126/scitranslmed.aax6337 Recent advances in targeted drug delivery strategy for enhancing oncotherapy J Li, Q Wang, G Xia, N Adilijiang, Y Li, Z Hou, Z Fan - Pharmaceutics, 2023 - mdpi.comhttps://www.mdpi.com/1999-4923/15/9/2233 Therapy-induced shaping of the glioblastoma microenvironment: Macrophages at play J Erbani, M Boon, L Akkari - Seminars in Cancer Biology, 2022 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1044579X22001122 Exosomes and extracellular vesicles as emerging theranostic platforms in cancer research G Ailuno, S Baldassari , F Lai, T Florio , G Caviglioli - Cells, 2020 - mdpi.comhttps://www.mdpi.com/2073-4409/9/12/2569 Phage-display-derived peptide binds to human CD206 and modeling reveals a new binding site on the receptor EK Asciutto , S Kopanchuk, A Lepland - The Journal of , 2019 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.jpcb.8b11876 Targeting the brain lesions using peptides: A review focused on the possibility of targeted drug delivery to multiple sclerosis lesions A Rayatpour , M Javan - Pharmacological Research, 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1043661821000244 Targeting pro-tumoral macrophages in early primary and metastatic breast tumors with the CD206-binding mUNO peptide A Lepland , EK Asciutto , A Malfanti - Molecular , 2020 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.0c00226 Peptide-based strategies for targeted tumor treatment and imaging A Ayo, P Laakkonen - Pharmaceutics, 2021 - mdpi.comhttps://www.mdpi.com/1999-4923/13/4/481 Peptide-Based Strategies for Targeted Tumor Treatment and Imaging. Pharmaceutics 2021, 13, 481 A Ayo, P Laakkonen - 2021 - academia.eduhttps://www.academia.edu/download/70607925/pdf.pdf Engineered exosomes for studies in tumor immunology A Alptekin , M Parvin , HI Chowdhury - Immunological , 2022 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/imr.13107

• Marke: Biosynth